| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 04/13/2005 | EP1446398B1 Manufacture of alpha- tocopherol |
| 04/13/2005 | CN1196693C Neutralizing agent for toxin of microorganism belonging to genus clostridium |
| 04/13/2005 | CN1196692C Substituted benzopyran derivatives for the treatment of inflammation |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878704 Heterocyclic mutilin esters and their use as antibacterials |
| 04/12/2005 | CA2214665C Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same |
| 04/07/2005 | WO2005030748A1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
| 04/07/2005 | WO2005030233A1 Active oxygen scavenging agent and process for producing the same |
| 04/07/2005 | WO2005007678A3 Methods for the preparation of rhodamine |
| 04/07/2005 | WO2004112715A3 Methods of making and using theaflavin,theaflavin-3-gallate, theaflavin-3’-gallate and theaflavin 3,3’ - digallate and mixtures thereof |
| 04/07/2005 | WO2004098283A3 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 04/07/2005 | US20050075388 Compounds as viricides for treatment of HTLV or aids |
| 04/07/2005 | US20050075379 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/07/2005 | US20050074748 Bioreactive agents |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | US20050074408 Compounds for fluorescent emission for animals |
| 04/07/2005 | CA2536791A1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
| 04/06/2005 | EP1519908A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 04/06/2005 | CN1603322A Manufacture of tocol, tocol derivatives and tocopherols |
| 04/06/2005 | CN1603321A Method for fixed bed transfer of natural vitamin E |
| 04/06/2005 | CN1603320A Method for preparing high content proanthocyanidin |
| 04/06/2005 | CN1603319A Separation purification method of catechin monomer |
| 04/06/2005 | CN1603318A Genistein derivatives and their preparation process and use |
| 04/06/2005 | CN1195750C Recovery of isoflavones from soy molasses |
| 04/06/2005 | CN1195513C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses |
| 04/05/2005 | US6875878 Chromene compound |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875745 Synergistic mixture of lapachone and taxane; anticancer, antitumor agents |
| 03/31/2005 | WO2005029189A1 Compound for resist and radiation-sensitive composition |
| 03/31/2005 | WO2005028472A1 Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| 03/31/2005 | WO2005028465A1 Chromene compound |
| 03/31/2005 | WO2005028464A1 Endurance improving agent |
| 03/31/2005 | WO2005028441A1 Cinnamoyl derivatives and use thereof |
| 03/31/2005 | WO2005027904A1 Hair restorer |
| 03/31/2005 | US20050070597 (3R, 4R)-trans-3, 4-diarylchroman derivatives and a method for the prevention and/or treatment of estrogen dependent diseases |
| 03/31/2005 | US20050069912 Energy transfer dyes with enhanced fluorescence |
| 03/31/2005 | DE10341154A1 New fluorinated tricyclic compounds useful as components of liquid crystal media for liquid crystal displays |
| 03/31/2005 | DE102004038800A1 Herstellung von Tocol, Tocolderivaten und Tocopherolen Production of tocol, Tocolderivaten and tocopherols |
| 03/31/2005 | CA2539644A1 Hair restorer |
| 03/31/2005 | CA2539162A1 Cinnamoyl derivatives and use thereof |
| 03/31/2005 | CA2538874A1 Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517997A2 Luminogenic protease substrates |
| 03/30/2005 | EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 03/30/2005 | EP1517884A1 A process for the preparation of 3-cyano-1-naphthoic acid and some analogues thereof |
| 03/30/2005 | EP1147100B1 Recovery of chroman derivatives |
| 03/30/2005 | CN1602307A Substituted 6h-dibenzo[c, h]chromenes as estrogenic agents |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1600755A General flavones of hawthorn fruit, preparation method and application |
| 03/30/2005 | CN1194983C Process for extracting anthoxyanin from cowbeery |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872838 Derivatives of water insoluble drugs which exhibit good activity and water solubility |
| 03/29/2005 | US6872746 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/24/2005 | WO2005026189A1 Process for the recovery of a phytolipid composition |
| 03/24/2005 | WO2005026181A2 A NEW ROUTE TO α-TOCOPHEROL, α-TOCOPHERYL ALKANOATES AND PRECURSORS THEREOF |
| 03/24/2005 | WO2005026143A1 Coumarins as inos inhibitors |
| 03/24/2005 | WO2005026142A2 Synthesis of alpha-tocopheryl alkanoates and precursors thereof |
| 03/24/2005 | WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 03/24/2005 | WO2005025500A2 Process for preparing water soluble diterpenes and their applications |
| 03/24/2005 | WO2004103985A3 Derivatives of fusarochromanone as therapeutic agents |
| 03/24/2005 | WO2004071426A3 Compounds for the treatment of viral infection |
| 03/24/2005 | WO2004046162A8 Non-steroidal fxr agonists |
| 03/24/2005 | WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 03/24/2005 | US20050065354 Administering prodrugs of metabolites such as 5-methyl-7-ethyl carbonate -isoflavone to increase concentration of flavonoids |
| 03/24/2005 | US20050065338 Total synthesis of galanthamine, analogues and derivatives thereof |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | US20050065150 Lipoxygenase moderators; autoimmune disease; neurodegenerative disease; respiratory system disorders; cardiovascular disorders; Alzheimer's disease; Parkinson's disease; amyotropic lateral sclerosis |
| 03/24/2005 | US20050065149 Neurodegenerative disorders; antiinflammatory agents; strokes; antiischemic agents; neuropathic pain; brain disorders; antiepileptic agents; Parkinson's disease ; amyotropic lateral sclerosis; Alzheimer's disease; antidiabetic agents |
| 03/24/2005 | US20050065099 Treatment of mitochondrial diseases |
| 03/24/2005 | US20050064308 Fluorescent probe for zinc |
| 03/24/2005 | US20050064050 Administering an effective amount of thearubigin, a type of brown-colored pigment component of black tea extracted from the leaves by water, hot water or an alcohol; an oxidative derivative of theaflavin (1-oxo,2,8,9-tri(hydroxy),4,6-bis(3,5,7-trihydroxy)chroman-2-yl)-benzocycloheptene; drugs; foods |
| 03/24/2005 | CA2537820A1 Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins |
| 03/23/2005 | CN1599602A Peroxisome proliferator activated receptor ligands and process for producing the same |
| 03/23/2005 | CN1597678A Extraction method of hawthorn leaf total flarone |
| 03/23/2005 | CN1597677A Compounds and methods for modulation of estrogen receptors |
| 03/23/2005 | CN1193997C Process for extracting high content mixed tocopherol |
| 03/23/2005 | CN1193996C Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent |
| 03/23/2005 | CN1193995C Method of extracting oligo proanthocyanidin of grape seed |
| 03/23/2005 | CN1193994C Method for purifying monomer of epigallocatechingallate (EGCG) |
| 03/23/2005 | CN1193993C Chrysanthemum total flavone resin purification method |
| 03/23/2005 | CN1193751C Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | WO2005023244A1 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof |
| 03/17/2005 | WO2005005356A3 Enantioselective synthesis of enantiomerically enriched compounds |
| 03/17/2005 | WO2004105779A3 Green tea and oplyphenol inhibitors of bacterial proteases |
| 03/17/2005 | WO2004025259A3 Site-specific labeling of affinity tags in fusion proteins |
| 03/17/2005 | WO2003043619A8 New use for the treatment of gastroesophageal reflux disease |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059708 Chemical intermediates of pioglitazone, rosiglitazone and troglitazone; starting inexpensive material, especially tyrosine; hypoglycemic agents, antidiabetic agent, antilipemic agents |
| 03/17/2005 | DE10337863A1 Verwendung von Chromen-4-on-Derivaten The use of chromene-4-one derivatives |
| 03/17/2005 | DE10337862A1 Chromen-4-on-Derivate Chromen-4-one derivatives |
| 03/17/2005 | DE10016449B4 Verbessertes Verfahren zur Isolierung des hepatoprotektiven Mittels Silymarin aus den Samen der Pflanze Silybum marianum An improved process for the isolation of hepatoprotective agent silymarin from the seeds of the plant Silybum marianum |
| 03/16/2005 | EP1514540A1 Calcium-containing tissue strengthening agents and use thereof |
| 03/16/2005 | EP1513870A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same |
| 03/16/2005 | EP1513802A1 Alpha-sulfonylamino-acetonitriles |
| 03/16/2005 | EP1513797A1 Agents and methods for the treatment of disorders associated with oxidative stress |
| 03/16/2005 | EP1513515A2 Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/16/2005 | EP1420779A4 Process for isolating phenolic compounds |
| 03/16/2005 | CN1596251A Piperazine derivatives having SST1 antagonistic activity |
| 03/16/2005 | CN1594308A Tectoridin isoflavone derivatives, their preparation process, and anti-virus medicines with tectoridin isoflavone derivatives as active components |